SETDB1 and head and neck squamous cell carcinoma: Kaplan–Meier analysis also revealed that the increased expression of SETDB1 was significantly correlated with the 5-year survival rate (50%) of patients with HNSCC (log-rank test, P = 0.009) (https://www.proteinatlas.org).